Neogen® Launches New Genomic Management Technology
Encompass™ platform advances how beef and dairy producers are able to sort and apply genomic data to herd selection and management. Neogen® Corporation (NASDAQ: NEOG) has launched the new...
Tag : human genome sequencing
Ordaōs and NonExomics Announce Research Collaboration
Ordaōs partners with NonExomics to create customized mini-proteins Ordaōs, a biotechnology company designing novel miniPROTM mini-proteins to help drug hunters deliver life-saving treatments, and NonExomics, a...
Eclipsebio Expands Intellectual Property Portfolio
Eclipse Bioinnovations, Inc. (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the completion of exclusive and co-exclusive...
P4 Diagnostix® Partners with Pierian to Launch Somatic Testing
P4 Enhances their NGS capabilities to offer Precision Medicine to their patients P4 Diagnostix®, a network of nationally recognized laboratories (“P4”), will be partnering with...
Omica.bio and GenoBank.io Partner
Population genomics startup omica.bio proudly announces its investment in web3 data management platform GenoBank.io. This new partnership is the next phase in both companies’ work...
LetsGetChecked Introduces myPGx
myPGx is the debut launch of LetsGetChecked’s new suite of genetics offerings, pioneering a full lifecycle of personalized, 360-degree healthcare from home LetsGetChecked, a leading healthcare...
Scribe Therapeutics Announces Research Collaboration with Sanofi
Sanofi selects Scribe’s CRISPR by Design™ platform to enable oncology pipeline of engineered natural killer (NK) cell therapies Scribe to grant Sanofi non-exclusive license to...
Chi-Biotech Launches Free-To-Use Sequencing Analysis Solution
The development enables gene sequencing companies and research institutions from all over the world to enjoy accurate and efficient analysis services while meeting the legal...
Allelica Launches Ancestry-Specific Polygenic Risk Score Tests
The clinical-grade, laboratory-developed test for polygenic risk score for coronary artery disease, breast cancer, prostate cancer, Type 2 Diabetes, and Alzheimer’s disease is now available...
Helix announces an extended agreement with CDC
Initial Helix-CDC Collaboration Led to Company’s Leadership in Identifying & Predicting the Timing of Dominant COVID Strains, Saving Countless Lives Helix, the leading population genomics...